Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel - PubMed (original) (raw)
Review
Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel
Pedro Gonçalves et al. Inflamm Bowel Dis. 2015 Feb.
Abstract
Epidemiological studies show that both the incidence of inflammatory bowel disease (IBD) and the proportion of people with obesity and/or obesity-associated metabolic syndrome increased markedly in developed countries during the past half century. Obesity is also associated with the development of more active IBD and requirement for hospitalization and with a decrease in the time span between diagnosis and surgery. Patients with IBD, especially Crohn's disease, present fat-wrapping or "creeping fat," which corresponds to ectopic adipose tissue extending from the mesenteric attachment and covering the majority of the small and large intestinal surface. Mesenteric adipose tissue in patients with IBD presents several morphological and functional alterations, e.g., it is more infiltrated with immune cells such as macrophages and T cells. All these lines of evidence clearly show an association between obesity, adipose tissue, and functional bowel disorders. In this review, we will show that the mesenteric adipose tissue and creeping fat are not innocent by standers but actively contribute to the intestinal and systemic inflammatory responses in patients with IBD. More specifically, we will review evidence showing that adipose tissue in IBD is associated with major alterations in the secretion of cytokines and adipokines involved in inflammatory process, in adipose tissue mesenchymal stem cells and adipogenesis, and in the interaction between adipose tissue and other intestinal components (immune, lymphatic, neuroendocrine, and intestinal epithelial systems). Collectively, these studies underline the importance of adipose tissue for the identification of novel therapeutic approaches for IBD.
Similar articles
- Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.
Bilski J, Mazur-Bialy A, Wojcik D, Surmiak M, Magierowski M, Sliwowski Z, Pajdo R, Kwiecien S, Danielak A, Ptak-Belowska A, Brzozowski T. Bilski J, et al. Biomolecules. 2019 Nov 26;9(12):780. doi: 10.3390/biom9120780. Biomolecules. 2019. PMID: 31779136 Free PMC article. Review. - Role of Adipose Tissue in Inflammatory Bowel Disease.
Karaskova E, Velganova-Veghova M, Geryk M, Foltenova H, Kucerova V, Karasek D. Karaskova E, et al. Int J Mol Sci. 2021 Apr 19;22(8):4226. doi: 10.3390/ijms22084226. Int J Mol Sci. 2021. PMID: 33921758 Free PMC article. Review. - Neuropeptides, mesenteric fat, and intestinal inflammation.
Karagiannides I, Pothoulakis C. Karagiannides I, et al. Ann N Y Acad Sci. 2008 Nov;1144:127-35. doi: 10.1196/annals.1418.009. Ann N Y Acad Sci. 2008. PMID: 19076372 Free PMC article. Review. - Role of fat and adipokines in intestinal inflammation.
Kredel L, Batra A, Siegmund B. Kredel L, et al. Curr Opin Gastroenterol. 2014 Nov;30(6):559-65. doi: 10.1097/MOG.0000000000000116. Curr Opin Gastroenterol. 2014. PMID: 25188546 Review. - The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease.
Eder P, Adler M, Dobrowolska A, Kamhieh-Milz J, Witowski J. Eder P, et al. Cells. 2019 Jun 21;8(6):628. doi: 10.3390/cells8060628. Cells. 2019. PMID: 31234447 Free PMC article. Review.
Cited by
- Inflammatory bowel disease-associated intestinal fibrosis.
Park JM, Kim J, Lee YJ, Bae SU, Lee HW. Park JM, et al. J Pathol Transl Med. 2023 Jan;57(1):60-66. doi: 10.4132/jptm.2022.11.02. Epub 2023 Jan 10. J Pathol Transl Med. 2023. PMID: 36623814 Free PMC article. Review. - Body Composition Changes and Related Factors in Patients with Ulcerative Colitis: A Retrospective Single-Center Study in China.
Wang R, Ding X, Tian Z, Jing X. Wang R, et al. Med Sci Monit. 2022 Mar 1;28:e933942. doi: 10.12659/MSM.933942. Med Sci Monit. 2022. PMID: 35231021 Free PMC article. - Adipose-Derived Stem Cells From Patients With Ulcerative Colitis Exhibit Impaired Immunosuppressive Function.
Wu X, Mu Y, Yao J, Lin F, Wu D, Ma Z. Wu X, et al. Front Cell Dev Biol. 2022 Feb 18;10:822772. doi: 10.3389/fcell.2022.822772. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35252190 Free PMC article. - Effect of sequential eradication therapy on serum osteoprotegerin levels in patients with Helicobacter pylori infection and co-existing inflammatory bowel disease.
Murad H, Rafeeq M, Mosli M, Gari M, Basheikh M. Murad H, et al. J Int Med Res. 2021 Nov;49(11):3000605211060648. doi: 10.1177/03000605211060648. J Int Med Res. 2021. PMID: 34851775 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous